Global Comprehensive Metabolic Panel Market Size (2024 - 2029)

The comprehensive metabolic panel market is experiencing growth driven by increasing awareness of early disease diagnosis and treatment, alongside the rising prevalence of chronic conditions such as diabetes and kidney diseases. Advancements in point-of-care technologies and the expanded demand for blood testing, particularly due to the COVID-19 pandemic, are further contributing to the market's expansion. The emphasis on early detection and rapid results from these tests is also a significant factor influencing the market size.

Home Market Analysis Healthcare Research Medical Devices Research Medical Supplies Research Medical Instruments Research Laboratory Medical Instruments Research Global Comprehensive Metabolic Panel Market Market Size

Market Size of Global Comprehensive Metabolic Panel Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Comprehensive Metabolic Panel Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 7.20 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Comprehensive Metabolic Panel Market Key Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Comprehensive Metabolic Panel Market Analysis

The comprehensive metabolic panel market is expected to register a CAGR of 7.2% during the forecast period, 2021-2026. The market is majorly driven by the growing awareness among the population regarding early diagnosis and treatment of diseases and the increasing prevalence of chronic diseases. Also, advancements in point-of-care technologies and diagnostics are expected to boost the market growth over the coming years.

With the increase in COVID-19 patients, the testing has expanded across the globe, which has stimulated the rise in blood tests being performed, and health officials expect a significant increase in the number of COVID-19 patients. Therefore, as the prevalence of COVID-19 increases, the demand for blood testing also increases, which further boosts the overall market.

According to the International Diabetes Federation, in 2019, there were about 463 million adults found living with diabetes, which is expected to reach 700 million by 2045. The rising burden of diabetes and efforts of governments and other organizations to increase awareness among the population are anticipated to boost the market over the forecast period.

According to the Regents of the University of California in 2018, there are nearly 750,000 patients per year in the United States alone, and the disease disproportionately affects the nation's minority and low-income patients. The estimates have also reported that there are around 2 million people worldwide suffering from end-stage renal disease (ESRD), and the number of patients diagnosed with the disease continues to increase at a rate of 5-7% per year. Countries such as Taiwan, Japan, Mexico, the United States, and Belgium currently have the highest prevalence of ESRD. Therefore, the increase in the prevalence of chronic diseases such as kidney diseases, diabetes, and liver diseases and emphasis of people on early diagnosis of these diseases are the factors responsible for the growth of the comprehensive metabolic panel (CMP) market.

The rise in demand for point-of-care testing for early detection and faster results by these tests are some other factors responsible for the growth of the market.

Comprehensive Metabolic Panel Industry Segmentation

As per the scope of the report, a comprehensive metabolic panel is the group of blood tests that provide information regarding the different body fluids, helping in the diagnosis of various diseases. This test is a preliminary test, and its results indicate liver diseases, kidney failure, or diabetes. Most blood tests take just a few minutes, and patients are advised 10 to 12 hours fast for proper test results. The comprehensive metabolic panel market is segmented by test type (proteins, kidney tests, electrolytes, liver function tests, glucose, and other tests), disease (kidney diseases, diabetes, liver diseases, and other diseases), end user (point-of-care centers and laboratories), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Test Type
Proteins
Kidney Tests
Electrolytes
Liver Function Tests
Glucose
Other Test Types
By Disease
Kidney Diseases
Diabetes
Liver Diseases
Other Diseases
By End User
Point-of-care Centers
Laboratories
Geography
North America
United States (By Test Type, Disease, and End User)
Canada (By Test Type, Disease, and End User)
Mexico (By Test Type, Disease, and End User)
Europe
Germany (By Test Type, Disease, and End User)
United Kingdom (By Test Type, Disease, and End User)
France (By Test Type, Disease, and End User)
Italy (By Test Type, Disease, and End User)
Spain (By Test Type, Disease, and End User)
Rest of Europe (By Test Type, Disease, and End User)
Asia-Pacific
China (By Test Type, Disease, and End User)
Japan (By Test Type, Disease, and End User)
India (By Test Type, Disease, and End User)
Australia (By Test Type, Disease, and End User)
South Korea (By Test Type, Disease, and End User)
Rest of Asia-Pacific (By Test Type, Disease, and End User)
Middle-East and Africa
GCC (By Test Type, Disease, and End User)
South Africa (By Test Type, Disease, and End User)
Rest of Middle-East and Africa (By Test Type, Disease, and End User)
South America
Brazil (By Test Type, Disease, and End User)
Argentina (By Test Type, Disease, and End User)
Rest of South America (By Test Type, Disease, and End User)
Need A Different Region Or Segment?
Customize Now

Global Comprehensive Metabolic Panel Market Size Summary

The comprehensive metabolic panel market is experiencing significant growth, driven by increasing awareness of the importance of early disease diagnosis and treatment, alongside the rising prevalence of chronic conditions such as diabetes, kidney, and liver diseases. The market is further propelled by advancements in point-of-care technologies and diagnostics, which facilitate quicker and more efficient testing. The COVID-19 pandemic has also contributed to market expansion, as the demand for blood testing has surged globally. This heightened demand is expected to continue as the prevalence of COVID-19 remains a concern, thereby boosting the overall market for comprehensive metabolic panels.

North America is anticipated to witness substantial growth due to its robust healthcare infrastructure, the presence of major industry players, and a large patient population. The region's market growth is also supported by favorable reimbursement policies and government initiatives. The competitive landscape of the comprehensive metabolic panel market is characterized by the presence of both local and international players, with companies focusing on strategic collaborations and geographic expansion to enhance their market share. Key players, including Quest Diagnostics and Laboratory Corporation of America Holdings, are actively engaging in product launches, mergers, and partnerships to maintain a competitive edge in this moderately competitive market.

Explore More

Global Comprehensive Metabolic Panel Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Awareness Regarding Early Diagnosis and Treatment of Diseases

      2. 1.2.2 Increasing Prevalence of Chronic Diseases

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Skilled Professionals

      2. 1.3.2 Stringent Regulatory Policies

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Test Type

      1. 2.1.1 Proteins

      2. 2.1.2 Kidney Tests

      3. 2.1.3 Electrolytes

      4. 2.1.4 Liver Function Tests

      5. 2.1.5 Glucose

      6. 2.1.6 Other Test Types

    2. 2.2 By Disease

      1. 2.2.1 Kidney Diseases

      2. 2.2.2 Diabetes

      3. 2.2.3 Liver Diseases

      4. 2.2.4 Other Diseases

    3. 2.3 By End User

      1. 2.3.1 Point-of-care Centers

      2. 2.3.2 Laboratories

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States (By Test Type, Disease, and End User)

        2. 2.4.1.2 Canada (By Test Type, Disease, and End User)

        3. 2.4.1.3 Mexico (By Test Type, Disease, and End User)

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany (By Test Type, Disease, and End User)

        2. 2.4.2.2 United Kingdom (By Test Type, Disease, and End User)

        3. 2.4.2.3 France (By Test Type, Disease, and End User)

        4. 2.4.2.4 Italy (By Test Type, Disease, and End User)

        5. 2.4.2.5 Spain (By Test Type, Disease, and End User)

        6. 2.4.2.6 Rest of Europe (By Test Type, Disease, and End User)

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China (By Test Type, Disease, and End User)

        2. 2.4.3.2 Japan (By Test Type, Disease, and End User)

        3. 2.4.3.3 India (By Test Type, Disease, and End User)

        4. 2.4.3.4 Australia (By Test Type, Disease, and End User)

        5. 2.4.3.5 South Korea (By Test Type, Disease, and End User)

        6. 2.4.3.6 Rest of Asia-Pacific (By Test Type, Disease, and End User)

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC (By Test Type, Disease, and End User)

        2. 2.4.4.2 South Africa (By Test Type, Disease, and End User)

        3. 2.4.4.3 Rest of Middle-East and Africa (By Test Type, Disease, and End User)

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil (By Test Type, Disease, and End User)

        2. 2.4.5.2 Argentina (By Test Type, Disease, and End User)

        3. 2.4.5.3 Rest of South America (By Test Type, Disease, and End User)

Global Comprehensive Metabolic Panel Market Size FAQs

The Global Comprehensive Metabolic Panel Market is projected to register a CAGR of 7.20% during the forecast period (2024-2029)

Quest Diagnostics, Laboratory Corporation of America Holdings, ARUP Laboratories., Synlab Hrvatska and UNIPATH are the major companies operating in the Global Comprehensive Metabolic Panel Market.

Global Comprehensive Metabolic Panel Report Snapshots

Comprehensive Metabolic Panel Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)